365 related articles for article (PubMed ID: 28144802)
1. Treatment of Elderly Patients With Acute Myeloid Leukemia.
Thomas X; Le Jeune C
Curr Treat Options Oncol; 2017 Jan; 18(1):2. PubMed ID: 28144802
[TBL] [Abstract][Full Text] [Related]
2. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
Ferrara F
Hematol Oncol; 2014 Mar; 32(1):1-9. PubMed ID: 23512815
[TBL] [Abstract][Full Text] [Related]
3. Emerging strategies for the treatment of older patients with acute myeloid leukemia.
Sanz MA; Iacoboni G; Montesinos P; Venditti A
Ann Hematol; 2016 Oct; 95(10):1583-93. PubMed ID: 27118541
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Relapsed/Refractory Acute Myeloid Leukemia.
Bose P; Vachhani P; Cortes JE
Curr Treat Options Oncol; 2017 Mar; 18(3):17. PubMed ID: 28286924
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy.
Oh SB; Park SW; Chung JS; Lee WS; Lee HS; Cho SH; Choi YS; Lim SN; Shin HJ;
Ann Hematol; 2017 Nov; 96(11):1801-1809. PubMed ID: 28828639
[TBL] [Abstract][Full Text] [Related]
6. The management and treatment of acute leukemias in the elderly population.
Thomas X
Expert Rev Hematol; 2017 Nov; 10(11):975-985. PubMed ID: 28931310
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia in the elderly: therapeutic options and choice.
Webster JA; Pratz KW
Leuk Lymphoma; 2018 Feb; 59(2):274-287. PubMed ID: 28573892
[TBL] [Abstract][Full Text] [Related]
8. Initial therapy for acute myeloid leukemia in older patients: principles of care.
Bhatt VR; Gundabolu K; Koll T; Maness LJ
Leuk Lymphoma; 2018 Jan; 59(1):29-41. PubMed ID: 28573900
[TBL] [Abstract][Full Text] [Related]
9. Future prospects of therapeutic clinical trials in acute myeloid leukemia.
Khan M; Mansoor AE; Kadia TM
Future Oncol; 2017 Mar; 13(6):523-535. PubMed ID: 27771959
[TBL] [Abstract][Full Text] [Related]
10. An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.
Ma E; Bonthapally V; Chawla A; Lefebvre P; Swords R; Lafeuille MH; Fortier J; Emond B; Duh MS; Dezube BJ
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):625-636.e3. PubMed ID: 27686689
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of TP53 is associated with poor survival, but not with reduced response to hypomethylating agents in older patients with acute myeloid leukaemia.
van der Helm LH; Berger G; Diepstra A; Huls G; Vellenga E
Br J Haematol; 2017 Sep; 178(5):810-812. PubMed ID: 27431572
[No Abstract] [Full Text] [Related]
12. Acute myeloid leukemia: advancing clinical trials and promising therapeutics.
Daver N; Cortes J; Kantarjian H; Ravandi F
Expert Rev Hematol; 2016 May; 9(5):433-45. PubMed ID: 26910051
[TBL] [Abstract][Full Text] [Related]
13. Panobinostat for the treatment of acute myelogenous leukemia.
Morabito F; Voso MT; Hohaus S; Gentile M; Vigna E; Recchia AG; Iovino L; Benedetti E; Lo-Coco F; Galimberti S
Expert Opin Investig Drugs; 2016 Sep; 25(9):1117-31. PubMed ID: 27485472
[TBL] [Abstract][Full Text] [Related]
14. [Acute myeloid Leukemia].
Braess J
Dtsch Med Wochenschr; 2016 Nov; 141(24):1748-1751. PubMed ID: 27835920
[TBL] [Abstract][Full Text] [Related]
15. Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant Disease.
Collinge E; Loron S; Larcher MV; Elhamri M; Heiblig M; Deloire A; Ducastelle S; Labussière H; Barraco F; Wattel E; Salles G; Paubelle E; Thomas X
Clin Lymphoma Myeloma Leuk; 2018 May; 18(5):e211-e218. PubMed ID: 29572159
[TBL] [Abstract][Full Text] [Related]
16. Management of primary refractory acute myeloid leukemia in the era of targeted therapies.
McMahon CM; Perl AE
Leuk Lymphoma; 2019 Mar; 60(3):583-597. PubMed ID: 30234399
[TBL] [Abstract][Full Text] [Related]
17. Emerging therapeutic modalities for acute myeloid leukemia (AML) in older adults.
Huang LW; Olin RL
J Geriatr Oncol; 2017 Nov; 8(6):417-420. PubMed ID: 28835351
[TBL] [Abstract][Full Text] [Related]
18. Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience.
Heiblig M; Le Jeune C; Elhamri M; Balsat M; Tigaud I; Plesa A; Barraco F; Labussière H; Ducastelle S; Nicolini F; Wattel E; Salles G; Thomas X
Leuk Lymphoma; 2017 Jan; 58(1):110-117. PubMed ID: 27184036
[TBL] [Abstract][Full Text] [Related]
19. [Acute leukemia in adults].
Eigendorff E; Hochhaus A
Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
[TBL] [Abstract][Full Text] [Related]
20. Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: Will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions?
Reikvam H; Kittang AO; Melve G; Mosevoll KA; Bentsen PT; Ersvær E; Gjertsen BT; Bruserud Ø
Curr Cancer Drug Targets; 2013 Jan; 13(1):30-47. PubMed ID: 22873213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
